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Abstract 
Background: A number of life threatening infections due to various bacterial pathogens are major cause of death in Pakistan. In a 
situation like the other developing countries, there is a general increase in the drug resistance due to the irrational use o f the antibiotics. 
The present study was carried out to evaluate the prevalence and development of resistance in Klebsiella pneumoniae against commonly 
used antibiotics. 
Methods and Materials: A total of 200 samples from different wards of the hospitals were received by the pathology laboratory of 
Pakistan Institute of Medical Sciences, Islamabad, which comprised of urine 65, blood 50 and other miscellaneous samples from various 
sources. Klebsiella pneumoniae was isolated and characterized using morphological, cultural, and biochemical methods and were further 
confirmed by using commercially available API 20E kit. The isolates were subjected to culture sensitivity test using Kirby Bauer disc 
diffusion method. 
Results: The organism was found to be the most prevalent Gram-negative bacilli. K. pneumoniae showed highest resistance against co-amoxiclav and 
cephalosporins. 
Conclusion: The study revealed that ESBL producing strains were resistant to most of the beta -lactam antibiotics. This trend therefore 
has become a significant problem and can be controlled with continued surveil lance or monitoring for rationally improved antibiotics 
usage, in order to prevent the drug resistance and re-emergence of infection. 
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Introduction 
Antimicrobial resistance is the ability of bacteria to resist the effects of an antibiotic or a mechanism that blocks the 
inhibitory or killing effects of antibiotics (Popovic et al., 2007). Beta -lactam antibiotics have been used as therapeutic agents 
since the 1940 as they are excellent drugs because they are non -toxic and well tolerated by most of the patients. The broad -
spectrum penicillins were soon followed by a large number of cephalosporin. (Conly, 2002). Antimicrobial resistance caused by  
ESBL has been found in many pathogenic Gram-negative bacteria but they are most common in nosocomial isolates of K. 
pneumoniae (Cheesbrough, 2005). Antimicrobial resistance can also occur as a result of random genetic mutations in bacteria, 
leading to variation in susceptibility within any bacterial population (Favre-Bonte and Licht, 1999, Feglo et al., 2010). 
Klebsiella pneumoniae is a non-motile Gram-negative rod-shaped bacterium, non-spore forming bacilli, which can grow both 
aerobically and anaerobically and are capsulated (Piranfar et al., 2014). Klebsiella species are known to cause a variety of 
human infections such as pneumonia , septicaemia, urinary tract infections, wound infection, meningitis, throat infection, intra -
abdominal abscess, brain abscess, and device related infection (Andrade, 2014).  
In recent studies most frequently identified bacteria were Escherichia coli (64.56%) and Klebsiella pneumoniae (13.78%). E-
coli were 61.35% resistant to trimethoprim, sulfamethoxazole and 49.6% resistant for Klebsiell a spp. Also intermediate resistance to 
nitrofurantion and tetracycline was also observed (Bergey's, 1994). There is association of important co -resistance and virulence 
factors in the K. pneumoniae, which makes this pathogen flourishing at infections and points to the quick evolution and expansion of 
this multi resistant as a virulent clone, leading to pan drug-resistant and persistent bacteria (Philipon et al 1989).  
. 
Materials and Methods 
Samples Collection 
The study was conducted at Pakistan Institute of Medical Science Islamabad (PIMS) and a total of 200 clinical samples i.e., 65 
urine, 50 blood, 22 pus, 20 tracheal secretions, 20 tissue and miscellaneous such as body fluids and infected wound swabs fro m out and 
in patients of different wards were collected . The collected specimens were labeled, including the sample type, date, and patient’s 
gender, as per hospital record and transported to the laboratory within recommended time period and then processed for furthe r studies. 
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Sample Processing 
Freshly drawn 3-5 ml blood was immediately transferred to 50 ml of Brain Heart Infusion (BHI) broth, and incubated at 37°C 
for 24 hours. Growth was sub-cultured on blood agar and MacConkey agar plates, and incubated for 24 hours at 37°C. For broth with 
no growth even after 48 hours were further incubated up to ten days, and observed the result. All urine samples were transferred  to 
sterile tubes for centrifugation and streaked on Cysteine-Lactose-Electrolyte Deficient (CLED) medium. The plates were incubated for 
24 to 48 hours at 37°C. The bacterial growth was sub-cultured on blood agar and MacConkey agar for further processing. Body fluids, 
pus, swabs samples were cultured on blood agar, MacConkey agar and XLD and incubated for 24 to 48 hours at 37°C. The b acterial 
isolates from all type of samples were identified up to species level and the susceptibility testing was done using disc diff usion 
method. For short term storage isolates were preserved on the nutrient agar slants. These slants were incubated for overnight at 35oC 
and placed at 4oC. For long term preservations, the bacterial isolates were preserved at -70oC on nutrient broth containing 30% (v/v) 
glycerol in screw capped tubes.  
Ident i f i cat ion of  B acteria l  Pathog ens  
Isolated colonies, after purification, were initially Gram stained by using Bergey’s Manual of Bacteriology (Jarlier et al., 1988). The isolates 
were characterized using biochemical tests i.e., triple sugar iron test, indole test, voges-Proskauer test (VP), motility test, citrate utilization test and 
oxidase test. API 20E was used for the micro standard system of specific identification of K. pneumoniae from the rest of the Gram negative rods 
using 20 microtubules with dehydrated substrates with the addition of bacterial suspension as inoculums (Al-Charrakh et al 2011). An anaerobic 
environment was created in tubules containing ADH, LCD, ODH, H2S, and UREA with a drop of mineral oil overlay as per manufacturer’s 
instructions. The incubation box was then incubated at 37C for 24 hours. 
Antibiotic Sensitivity Test 
Antimicrobial susceptibility testing was carried out by the standard Kirby-Bauer disk diffusion method on Muller-Hinton agar following 
guidelines provided by Clinical and Laboratory Standards Institute (CLSI) 2010. 
Detection of ESBL 
For detection of ESBL-production, double disc method of (Jarlier et al 1988) was used to observe the ESBL production. 
The identified Gram negative organisms were swabbed onto a Mueller -Hinton agar plate. A susceptibility disc of co-amoxiclav 
(20µg amoxicillin/ 10µg clavulanic acid) was placed in the center of the agar surface. The discs of ceftriaxon and ceftazidime 
(30µg each) were arranged in such a way that the distance between the central disc and surrounding discs was approximately 30  
mm. After 30 minutes of pre-incubation time, the plates were incubated aerobically at 35 C for 24hrs. If the inhibition zone 
around one or more cephalosporin discs was extended on the side nearest to the co -amoxiclav disc, the organism showed an ESBL 
production. If no extension of zones of third generation of cephalosporin towards co -amoxiclav disc was observed, the organisms 
were considered as non-producer of ESBLs. 
Results and Discussion 
ESBL Production in K. Pneumoniae 
Out of 200 ß-lactamase (ESBL) producing isolates, 175 (87.5%) ESBL positive and 25 (12.55%) ESBL negative organisms were detected 
by double disk diffusion method (Figure 1) and this pattern was similar as in another finding by Al-Charrakh et al., 2011. 
 
Figure 1: The total samples distribution pattern for K. Pneumoniae isolates 
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Figure 2: Gender wise distribution of K. Pneumoniae infection 
 
Figure 3: Age wise distribution of K. Pneumoniae infection 
Microbial Analysis 
Isolates were identified by their growth on different media, MacConkey agar, blood agar, xylose lysine deoxicholate (XLD) and cysteine 
lactose electrolyte deficient (CLED). Colonies were observed after 24 hours of incubation as pink , bright yellow and whitish grey colonies on 
MacConky agar, XLD, CLED and blood agar; respectively. These observations are generally noted as similarly observed in a study by (Shah et al., 
2000, Mumtaz et al., 2008). 
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Figure 4: Growth of Klebsiella pneumoniae on MacConky and Blood agar 
Figure 5: Growth of Klebsiella pneumoniae on CLED and XLD culture media 
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Gram Staining Result 
All 200 samples were Gram stained to observe the morphological characteristics of K. Pneumoniae under microscope. It was observed that K. 
Pneumoniae was Gram negative as it appeared thick pink rod as shown in (Figure 6), these results are supported by other researchers and are in 
according to the Bergey’s Manual of Determinative Bacteriology. 
 
Figure 6: Microscopic appearance of K. Pneumoniae 
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Biochemical Characteristics of K. Pneumoniae 
For biochemical characterization, a series of biochemical tests for K. pneumoniae were manually performed such as citrate, VP, TSI, 
motility, indole and oxidase and were compared with API 20 E analysis. Our results were compatible with (Winn et al., 2006, Murray et al., 2007). 
Table: 1. Biochemical Characteristics of K. pneumoniae 
  Biochemical Characteristics 
Test Results   Change In Growth Media 
Citrate +ive   Green to Blue 
Motility -ive   No Turbidity no Growth 
Indole -ive   Oily Band on Top Not Red In Colour 
Voges-Proskauser +ive   Pink-Red in colour 
Oxidase -ive   No color change 
Triple Sugar Iron +ive   Light Pink(alkaline),  
 
Figure 7: Voges-Proskauer , Citrate , Indole and Motility tests 
Results on API 20E System 
The biochemically identified samples of K. pneumoniae when analyzed on API 20E system on an API strip, a conversion numerical value was 
obtained. The generated number from API 20E system for K .pneumoniae was then checked in the catalogue book and was identified 95 percent up to 
species level. (Figure 8) Results showed similarity with findings by (Carson et al., 2001). 
Figure 8: Results of API20E for confirmation of K. Pneumoniae  
Antibiotic Susceptibility Pattern of Isolates 
In the present study, most commonly used antibiotics discs were subjected to determine the Klebsiella pneumonia sensitivity. Antibiotic 
sensitivity of K. pneumoniae was observed by disc diffusion method in which fourteen different antibiotics were applied. The sensitivity of K. 
pneumoniae was checked with help of list of break points of zone of inhibition and to consider resistant one when zone of inhibition did not fall 
into the values of break points. The results showed that among fourteen conventional drugs K. pneumoniae showed highest 
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resistance against co-amoxiclav, i.e., 100%. The next highest resistance was for cephalosporin, such as ceftazidime, ceftriaxone followed by 
Piperacillin-tazobactum, norfloxacin, cefoperazon+sulbactum, gentamycin, tobramycine, amikacin, piperacillin, imipenem and meropenem. 
Isolates were found to be resistant to all classes of antibiotics except polymixin B. The (Al -Zahrani et al., 2005), also determined antimicrobial 
sensitivity test by using different antibiotics and found that K. pneumoniae was sensitive to meropenem, imipenem. The resistance against 
different similar drugs was also reported by (Chaikittisuk et al., 2007). 
Table 2: Antibiotic sensitivity pattern of specimens referred from surgical ward 
Antibiotics Resistance  
Count (%age) 
Intermediat  
Count (%age) 
Sensitive  
Count (%age) 
Total  
Count 
Amoxicillin 52(100) 0(0.00) 0(0.00) 52 
Ceftazidime 44(89.7) 2(4.0) 3(6.10) 49 
Ceftriaxone 54(100) 0(0.00) 0(0.00) 54 
Tazobactum 48(84.2) 3(5.2) 6(10.5) 57 
Norithindrone 35(83) 2(4.7) 5(11.5) 42 
Gentamicin 30(60) 0(0.00) 20(40) 50 
Tobramycin 24(40) 1(1.6) 35(58) 58 
Amikacin 19(38) 0(0.00) 31(62) 50 
Piperacillin 17(34.6) 10(20.0) 22(44.8) 49 
Levofloxacine 5(9.0) 0(0.00) 50(90) 55 
Meropenem 2(3.8) 0(0.00) 50(96) 52 
Polymixine B 0(0.00) 0(0.00) 50(100) 50  
Table: 3: Antibiotic sensitivity pattern of specimens referred from medical ward 
Antibiotics Resistance  
Count (%age) 
Intermediat  
Count (%age) 
Sensitive  
Count (%age) 
Total  
Count 
Amoxicillin 50(100) 0(0.00) 0(0.00) 50 
Piperacillin 47(95.5) 1(2.0) 1(2.0) 49 
Ceftriaxone 45(93.7) 2(4.1) 1(2.0) 48 
Tazobactum 35(89.7) 1(2.5) 3(7.6) 39 
Norithindrone 40(83) 1(2.0) 7(14) 48 
Gentamicin 20(39) 1(1.9) 28(54) 49 
Tobramycin 22(48) 2(4.4) 23(51) 47 
Amikacin 20(41) 0(0.00) 28(58) 48 
Piperacillin 20(34) 9(15) 29(50) 58 
Levofloxacine 5(9.0) 0(0.00) 50(90) 55 
Meropenem 3(6.5) 0(0.00) 43(93) 46 
Polymixine B 0(0.00) 0(0.00) 49(100) 49  
Table: 4: Antibiotic sensitivity pattern of specimen’s referred from outpatient department  
Antibiotics Resistance  
Count (%age) 
Intermediat  
Count (%age) 
Sensitive  
Count (%age) 
Total  
Count 
Amoxicillin 55(100) 0(0.00) 0(0.00) 55 
Ceftazidime 50(89) 2(3.5) 4(7.1) 56 
Ceftriaxone 49(96) 1(1.9) 1(1.9) 51 
Tazobactum 48(87.5) 2(4.0) 4(8.0) 54 
Norithindrone 57(93) 1(1.6) 3(4.9) 61 
Gentamicin 26(53) 0(0.00) 23(46.9) 49 
Tobramycin 24(52) 1(2.0) 27(58) 52 
Amikacin 22(36) 0(0.00) 39(63.9) 61 
Piperacillin 19(38) 22(11) 20(40) 61 
Levofloxacine 4(8.6) 1(2.1) 41(89) 45 
Meropenem 4(7.8) 0(0.00) 53(92) 57 
Polymixine B 0(0.00) 0(0.00) 50(100) 50  
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Table: 5: Antibiotic sensitivity pattern of specimens referred from intensive care unit 
Antibiotics Resistance  
Count (%age) 
Intermediat  
Count (%age) 
Sensitive  
Count (%age) 
Total  
Count 
Amoxicillin 43(95) 0(0.00) 2(4.4) 45 
Ceftazidime 43(97) 0(0.00) 1(2.0) 44 
Ceftriaxone 47(100) 0(0.00) 0(0.00) 47 
Tazobactum 51(91) 2(3.5) 3(5.3) 56 
Norithindrone 43(87) 1(2.0) 5(10) 49 
Gentamicin 24(45) 2(3.7) 26(46) 52 
Tobramycin 27(57) 0(0.00) 20(42) 47 
Amikacin 14(34) 0(0.00) 27(65.8) 41 
Piperacillin 14(32.5) 10(23) 19(44) 43 
Levofloxacine 6(10.9) 0(0.00) 49(89) 55 
Meropenem 3(6.6) 0(0.00) 52(93.3) 55 
Polymixine B 0(0.00) 0(0.00) 50(100) 50  
Acquired bacterial resistance is common among clinical isolates from healthy persons as well as patients having community -
acquired infections in developing countries. K. pneumoniae was observed to be resistant against ciprofloxacin, amoxacilline-clavulanic 
acid and gentamicin. Polymixin B and meropenem were the drugs considerably effective against K. pneumoniae along with other high 
spectrum third generation antibiotics. In conclusion, antimicrobial resistance is widespread among hospital and community-acquired 
pathogens in Pakistan. Monitoring ESBL production and antimicrobial susceptibility testing are necessary to reduce the burden  of 
increasingly resistant pathogens (Asti 2013). Therefore, the antibiotic stewardship guidelines need to be recommended and strictly 
adopted in a comprehensive control program to reduce the high levels of bacterial antibiotic resistance (Mohanalakshmi et al.  2014). In 
this study, the prevalence of the ESBLs was highest in K. pneumonia which is an indication of increased resistance. However, in the 
industrialized world, education of the medical professionals regarding the use of antimicrobial agents seems to be the single  most 
important tool in avoiding further development of resistance and to minimize the problems.,  
Conclusions 
The study revealed that ESBL producing strains were resistant to most of the beta -lactam antibiotics. This trend, therefore, 
has become a significant problem and can be controlled with continued surveillance or monitoring for rationally improved antibiotics 
usage, in order to prevent the drug resistance and re-emergence of infection. 
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